Literature DB >> 14689589

Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer.

Andrew H Fischer1, Svetoslav Bardarov, Zhong Jiang.   

Abstract

Prostate cancer is still diagnosed by pathologists based on subjective assessment of altered cell and tissue structure. The cellular-level structural changes diagnostic of some forms of cancer are known to be induced by cancer genes, but the relation between specific cellular-level structural features and cancer genes has not been explored in the prostate. Two important cell structural changes in prostate cancer-nucleolar enlargement and nuclear envelope (NE) irregularity-are discussed from the perspective that they should also relate to the function of the genes active in prostate cancer. Enlargement of the nucleolus is the key diagnostic feature of high-grade prostatic intraepithelial neoplasia (PIN), an early stage that appears to be the precursor to the majority of invasive prostate cancers. Nucleolar enlargement classically is associated with increased ribosome production, and production of new ribosomes appears essential for cell-cycle progression. Several cancer genes implicated in PIN are known (in other cell types) to augment ribosome production, including c-Myc, p27, retinoblastoma, p53, and growth factors that impact on ERK signaling. However, critical review of the available information suggests that increased ribosome production per se may be insufficient to explain nucleolar enlargement in PIN, and other newer functions of nucleoli may therefore need to be invoked. NE irregularity develops later in the clonal evolution of some prostate cancers, and it has adverse prognostic significance. Nuclear irregularity has recently been shown to develop dynamically during interphase following oncogene expression, without a requirement for post-mitotic NE reassembly. NE irregularity characteristic of some aggressive prostate cancers could reflect cytoskeletal forces exerted on the NE during active cell locomotion. NE irregularity could also promote chromosomal instability because it leads to chromosomal asymmetry in metaphase. Finally, NE irregularity could impact replication competence, transcriptional programming and nuclear pore function. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14689589     DOI: 10.1002/jcb.10735

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

Review 1.  An architectural genetic and epigenetic perspective.

Authors:  Gary S Stein; Janet L Stein; Andre J van Wijnen; Jane B Lian; Sayyed K Zaidi; Jeffrey A Nickerson; Martin A Montecino; Daniel W Young
Journal:  Integr Biol (Camb)       Date:  2010-12-24       Impact factor: 2.192

2.  Loss of the integral nuclear envelope protein SUN1 induces alteration of nucleoli.

Authors:  Ayaka Matsumoto; Chiyomi Sakamoto; Haruka Matsumori; Jun Katahira; Yoko Yasuda; Katsuhide Yoshidome; Masahiko Tsujimoto; Ilya G Goldberg; Nariaki Matsuura; Mitsuyoshi Nakao; Noriko Saitoh; Miki Hieda
Journal:  Nucleus       Date:  2016-03-10       Impact factor: 4.197

3.  Role of nuclear architecture in epigenetic alterations in cancer.

Authors:  H P Easwaran; S B Baylin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-03-29

4.  Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene.

Authors:  Cheryl M Koh; Bora Gurel; Siobhan Sutcliffe; Martin J Aryee; Denise Schultz; Tsuyoshi Iwata; Motohide Uemura; Karen I Zeller; Uzoma Anele; Qizhi Zheng; Jessica L Hicks; William G Nelson; Chi V Dang; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

Review 5.  The dynamic architectural and epigenetic nuclear landscape: developing the genomic almanac of biology and disease.

Authors:  Phillip W L Tai; Sayyed K Zaidi; Hai Wu; Rodrigo A Grandy; Martin Montecino; André J van Wijnen; Jane B Lian; Gary S Stein; Janet L Stein
Journal:  J Cell Physiol       Date:  2014-06       Impact factor: 6.384

6.  Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation.

Authors:  M Uemura; Q Zheng; C M Koh; W G Nelson; S Yegnasubramanian; A M De Marzo
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

7.  Single Cell Assay for Molecular Diagnostics and Medicine: Monitoring Intracellular Concentrations of Macromolecules by Two-photon Fluorescence Lifetime Imaging.

Authors:  Artem Pliss; Xiao Peng; Lixin Liu; Andrey Kuzmin; Yan Wang; Junle Qu; Yuee Li; Paras N Prasad
Journal:  Theranostics       Date:  2015-05-15       Impact factor: 11.556

8.  Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies.

Authors:  Peter H Gann; Ryan Deaton; Anup Amatya; Mahesh Mohnani; Erika Enk Rueter; Yirong Yang; Viju Ananthanarayanan
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

Review 9.  Nuclear assembly as a target for anti-cancer therapies.

Authors:  Mátyás Gorjánácz
Journal:  Nucleus       Date:  2014-01-27       Impact factor: 4.197

10.  Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem.

Authors:  Gianni Bussolati; Caterina Marchiò; Laura Gaetano; Rosanna Lupo; Anna Sapino
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.